...Gene therapy play Adverum Biotechnologies Inc. (NASDAQ:ADVM) named Leone Patterson CFO. She was CFO at Diadexus Inc....

...in diaDexus stock at about $3.82 per share, which is about a 27% premimum to Diadexus’...
...closed at $3.01 on Sept. 4, the last trading day before the deal was announced. Diadexus...
...will supply OriGene materials and reagents for PLAC ELISA on a cost plus profit basis. Diadexus...

...OneMed AB (Danderyd, Sweden). Lind was VP of business development at LifeCell Corp. (Branchburg, N.J.). diaDexus Inc....

...Last month, FDA granted 510(k) clearance to the PLAC Test for Lp-PLA2 Activity from diaDexus as...
...measures lipoprotein-associated phospholipase A2 ( PLA2G7 ; PAFAH ; Lp-PLA2) in human plasma and serum. diaDexus Inc....

...2018. The lender also received seven-year warrants to purchase up to 909,090 shares at $0.66. diaDexus...

...Lp-PLA2) in human plasma and serum. The test has CE Mark approval in Europe. diaDexus’...
...aid in predicting risk for coronary heart disease (CHD) and ischemic stroke associated with atherosclerosis. diaDexus Inc....

...intra-abdominal infections (cIAIs) and complicated urinary tract infections (cUTIs) Submit MAA; PDUFA date 2H14; 12/21/14 diaDexus Inc....